Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. - Futterer SF; Nemeth AJ; Grimm SA; Ragin AB; Chandler JP; Muro K; Marymont MH; Raizer JJ (Journal of neuro-oncology, 2014)